Urine High-Sensitivity Troponin I Predict Incident Cardiovascular Events in Patients with Diabetes Mellitus

Ju-Yi Chen1, Shuenn-Yuh Lee2, Yi-Heng Li1

  • 1Division of Cardiology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.

Insights

Urinary high-sensitivity troponin I (hs-TnI) can predict cardiovascular events in diabetes mellitus patients. This non-invasive biomarker offers a promising tool for early risk assessment in diabetic individuals.

Area of Science:

  • Cardiology
  • Diabetology
  • Biomarker Research

Background:

  • Cardiovascular (CV) events significantly worsen outcomes for patients with diabetes mellitus (DM).
  • Serum high-sensitivity troponin I (hs-TnI) is established for acute coronary syndrome but its utility in urine for DM patients is under-researched.
  • Predicting incident CV events in DM requires accessible and reliable biomarkers.

Purpose of the Study:

  • To investigate the accuracy of urine hs-TnI as a predictor of incident CV events in patients with DM.
  • To establish the diagnostic and prognostic value of urinary hs-TnI in a diabetic cohort.
  • To determine an optimal cutoff value for urine hs-TnI for CV event prediction.

Main Methods:

  • Prospective study involving 378 patients with DM.
  • Measurement of fresh urine hs-TnI levels.
  • Follow-up for incident CV events over 3 months using medical records.

Main Results:

  • Significantly higher urine hs-TnI levels were observed in patients who experienced subsequent CV events.
  • Multivariate logistic regression identified urine hs-TnI > 4.10 pg/mL as an independent predictor of incident CV events.
  • ROC-AUC analysis indicated an optimal cutoff of 1.55 pg/mL for urine hs-TnI, with an area of 0.611 (p=0.027).

Conclusions:

  • Urinary hs-TnI is a potential non-invasive biomarker for predicting incident CV events in patients with DM.
  • A single urine hs-TnI measurement may be a convenient and acceptable method for CV risk assessment in this population.
  • Further research can validate urine hs-TnI for routine clinical use in managing diabetic cardiovascular risk.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
591
Urine Studies I: Urinalysis01:29

Urine Studies I: Urinalysis

Urinalysis is a widely used diagnostic test that analyzes urine's physical, chemical, and microscopic characteristics. Healthcare providers use it to detect and monitor various health conditions, including renal disease, urinary tract infections (UTIs), diabetes, and metabolic or systemic disorders.Components of UrinalysisUrinalysis consists of three primary components: physical, chemical, and microscopic examination. Each provides unique insights into the urine sample and, by extension, the...
680
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
368
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.6K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
101
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
156